Alx Oncology Holdings (ALXO) Current Assets (2019 - 2026)

Alx Oncology Holdings' Current Assets history runs 8 years deep, the most recent figure standing at $145.6 million for Q1 2026.

• In Q1 2026, Current Assets rose 41.97% year-over-year to $145.6 million; the TTM figure through Mar 2026 stood at $145.6 million (up 41.97% YoY), while the FY2025 annual figure was $50.7 million, down 62.24% from the prior year.
• Current Assets came in at $145.6 million for Q1 2026 at Alx Oncology Holdings, up from $50.7 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $321.5 million in Q1 2022 to a low of $50.7 million in Q4 2025.
• A 5-year average of $183.4 million and a median of $168.7 million in 2024 frame the typical range for Current Assets.
• Across the five-year window, Current Assets slumped 62.24% in 2025 and surged 41.97% in 2026, its largest moves.
• Alx Oncology Holdings' Current Assets stood at $271.0 million in 2022, then sank by 30.38% to $188.7 million in 2023, then declined by 28.79% to $134.4 million in 2024, then plunged by 62.24% to $50.7 million in 2025, then jumped by 186.96% to $145.6 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $145.6 million, $50.7 million, and $66.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison